Business Context and Reporting Period
This Form 8-K Current Report was filed by TriSalus Life Sciences, Inc. on April 17, 2025, covering an event that occurred on April 16, 2025. The company is incorporated in Delaware and trades on the Nasdaq Global Market under the symbols TLSI (Common Stock) and TLSIW (Warrants).
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial statements or performance data.
Material Changes
The material change reported is the immediate resignation of Liselotte Hyveled from the following positions:
- Member of the Board of Directors
- Member of the Nominating and Corporate Governance Committee
- Member of the Science and Technology Committee
The Company stated that the resignation is not the result of any disagreement with the Company regarding its operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. No specific risks, contingencies, or unusual items were disclosed in this report beyond the standard disclosure of the director's departure.
Key Facts for Investor Verification
- Verify the effective date of Liselotte Hyveled's resignation (April 16, 2025).
- Confirm whether the Board has initiated a search for a replacement director.
- Check subsequent filings for any impact on committee quorum or governance structure.
- Note that no financial data is included in this specific 8-K filing.